Clearfield (CLFD) COO John Hill exercises options, sells 27,395 shares
John P. Hill, Chief Operating Officer and director of Clearfield, Inc. (CLFD), reported option exercises and subsequent share dispositions on 09/18/2025.
Rhea-AI Filing Summary
John P. Hill, Chief Operating Officer and director of Clearfield, Inc. (CLFD), reported option exercises and subsequent share dispositions on 09/18/2025. He exercised 17,776 options with an exercise price of $23.74 and 24,000 options with an exercise price of $12.43, increasing beneficial ownership to 180,520 shares at one point. He also disposed of 14,000 shares and 13,395 shares by sale at $34.21 per share, leaving a reported beneficial ownership of 167,125 shares. The filings note the exercises occurred because the options were approaching expiration dates in November 2025. The Form 4 was signed by power of attorney on 09/22/2025.
Positive
- Options exercised before expiration (17,776 at $23.74 and 24,000 at $12.43), demonstrating conversion of vested compensation into equity
- Transparent reporting of exercise, sale prices, and resulting beneficial ownership with explanatory notes on vesting
- Retained substantial ownership after transactions: 167,125 shares reported beneficially owned
Negative
- Insider sold shares (14,000 and 13,395) at $34.21, reducing total holdings
- Exercise and sale activity concentrated on a single day (09/18/2025), which could momentarily increase share supply
Insights
TL;DR: Routine option exercises and partial sales; modest change in insider holdings, not an unusual disclosure.
The filing shows the COO exercised vested employee stock options (17,776 at $23.74 and 24,000 at $12.43) as they neared expiration, then sold a portion of the resulting shares (14,000 and 13,395) at $34.21. Net reported beneficial ownership remains substantial at 167,125 shares. This pattern—exercising to capture vested value and selling some shares—is common when options near expiry and does not by itself indicate a change in company fundamentals.
TL;DR: Disclosure is timely and conforms to Section 16 reporting for option exercises and sales.
The Form 4 documents option vesting schedules and exercises tied to upcoming expirations, with explanatory notes clarifying vesting tranches. The use of a power of attorney signature is disclosed. Transactions are itemized with exercise prices, sale prices, and post-transaction ownership counts, providing transparency for shareholders and regulators.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 17,776 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to buy) | 24,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 17,776 | $23.74 | $422K |
| Exercise Price or Tax Liability | Common Stock | 14,000 | $34.21 | $479K |
| Exercise | Common Stock | 24,000 | $12.43 | $298K |
| Exercise Price or Tax Liability | Common Stock | 13,395 | $34.21 | $458K |
Footnotes (4)
- F1. Exercised as options were set to expire on November 16, 2025.
- F2. Exercised as options were set to expire on November 13, 2025.
- F3. The stock option exercised vested in 1/3rd increments beginning 11/16/2021 through 11/16/2023.
- F4. The stock option exercised vested in 1/5th increments beginning 11/13/2020 through 11/13/2024.
FAQ
Who filed the Form 4 for Clearfield, Inc. (CLFD)?
What option exercises are reported on the Form 4 for CLFD?
What was the reported beneficial ownership after these transactions?
Why were the options exercised according to the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.